A detailed history of Eaton Financial Holdings Company, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Eaton Financial Holdings Company, LLC holds 44,030 shares of ESPR stock, worth $96,425. This represents 0.03% of its overall portfolio holdings.

Number of Shares
44,030
Previous 34,030 29.39%
Holding current value
$96,425
Previous $91.2 Million 20.34%
% of portfolio
0.03%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 22, 2024

BUY
$1.61 - $2.73 $16,100 - $27,300
10,000 Added 29.39%
44,030 $72.7 Million
Q4 2023

Feb 12, 2024

BUY
$0.73 - $3.08 $24,841 - $104,812
34,030 New
34,030 $102 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $146M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Eaton Financial Holdings Company, LLC Portfolio

Follow Eaton Financial Holdings Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Financial Holdings Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Financial Holdings Company, LLC with notifications on news.